Molecular Initiating Events Associated with Drug-Induced Liver Malignant Tumors: An Integrated Study of the FDA Adverse Event Reporting System and Toxicity Predictions

Liver malignant tumors (LMTs) represent a serious adverse drug event associated with drug-induced liver injury. Increases in endocrine-disrupting chemicals (EDCs) have attracted attention in recent years, due to their liver function-inhibiting abilities. Exposure to EDCs can induce nonalcoholic fatt...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurosaki, Kota, Uesawa, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301945/
https://www.ncbi.nlm.nih.gov/pubmed/34202146
http://dx.doi.org/10.3390/biom11070944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301945/
https://www.ncbi.nlm.nih.gov/pubmed/34202146
http://dx.doi.org/10.3390/biom11070944

Ejemplares similares